StageZero Life Sciences Ltd T.SZLS

Alternate Symbol(s): SZLSF

Healthcare Biotechnology

StageZero Life Sciences, Ltd. is a Canada-based vertically integrated healthcare company. The Company is engaged in improving the early detection and management of cancer and other chronic diseases through diagnostics and telehealth programs that provide clinical interventions to assist patients who have cancer (COC Protocol), and help patients reduce the risk of developing late-stage disease (AVRT). Its test, Aristotle, is the first mRNA multi-cancer panel for simultaneously screening for multiple cancers from a single sample of blood with high sensitivity and specificity for each cancer. Aristotle uses mRNA technology to identify the molecular signatures of multiple cancer types and is built on the Company's patented technology platform, the Sentinel Principle. The Care Oncology Clinic offers a supervised treatment regimen (the COC Protocol) for people diagnosed with cancer of any type or stage. Its ColonSentry is a proprietary blood test for screening for Colorectal Cancer.

TSX:SZLS - Post by User

StageZero Life Sciences Ltd > Ask at 0.77?

<< Previous

Bullboard Posts

Next >>

Comment by Bucky86on Nov 18, 2020 4:54pm

193 Views

Post# 31926473

RE:Ask at 0.77?

I really thought there was going to be more anticipation and excitement from buyers leading up to these financials. Kind of concerning that it hasn't been this way. I guess everyone is sitting on their hands until they are shown some hard results

<< Previous

Bullboard Posts

Next >>

The long-term forecast for lithium stocks in 2024